Diabetic Ketoacidosis Induced by Aripiprazole in a 12-Year-Old Boy | Zendy

Radhika Dhamija | Zendy; Rajanshu Verma | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Diabetic Ketoacidosis Induced by Aripiprazole in a 12-Year-Old Boy

Author(s) -

Radhika Dhamija,

Rajanshu Verma

Publication year - 2008

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc08-0441

Subject(s) - medicine , aripiprazole , diabetic ketoacidosis , diabetes mellitus , ketoacidosis , pediatrics , psychiatry , endocrinology , type 1 diabetes , schizophrenia (object oriented programming)

Aripiprazole is a relatively new atypical antipsychotic drug used to treat aggression, bipolar disorder, conduct and mood disorder, and Tourette's syndrome in children and schizophrenia-related mood disturbances in adults. It is believed to have fewer side effects such as weight gain, pancreatitis, and hyperglycemia (1,2). We report a 12-year-old boy who presented with diabetic ketoacidosis (DKA) due to Aripiprazole use.A 12-year-old Caucasian boy with a history of intractable epilepsy, mental retardation, …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research